Rani Therapeutics Holdings, Inc.
RANI • NASDAQ
Rani Therapeutics Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Talat Imran, with a market cap of $80.8M.
CEOTalat Imran
Next Earnings
Upcoming earnings announcement for Rani Therapeutics Holdings, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.14
Revenue Estimate
$2.3M
Earnings History
Past 12 earnings reports for Rani Therapeutics Holdings, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.07Est: -$0.05 | -40.0% | $1.5MEst: $7.0M | -79.1% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.12Est: -$0.11 | -9.1% | -Est: $4.0M | -100.0% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.18Est: -$0.19 | +5.3% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.22 | — | $172.0K | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.27Est: -$0.23 | -17.4% | $1.0M | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.24Est: -$0.27 | +11.1% | - | — | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.26Est: -$0.32 | +18.8% | - | — | 10-Q |
| May 6, 2024 | Q1 2024 | -$0.29Est: -$0.31 | +6.5% | - | — | 10-Q |
| Mar 20, 2024 | Q4 2023 | -$0.27Est: -$0.31 | +12.9% | - | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.36Est: -$0.37 | +2.7% | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$0.37Est: -$0.40 | +7.5% | - | — | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.33Est: -$0.41 | +19.5% | - | — | — |